UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 242

Sortiert nach

Immune-related adverse events in various organs caused by immune checkpoint inhibitors

Allergology international, 2022-04, Vol.71 (2), p.169-178

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical Features and Cutaneous Manifestations of Juvenile and Adult Patients of Dermatomyositis Associated with Myositis-Specific Autoantibodies

Journal of clinical medicine, 2021-04, Vol.10 (8), p.1725

Okiyama, Naoko

2021

Link zum Volltext

Verfügbarkeit prüfen

Recent advances in dermatomyositis-specific autoantibodies

Current opinion in rheumatology, 2016-11, Vol.28 (6), p.636-644

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical perspectives and murine models of lichenoid tissue reaction/interface dermatitis

Journal of dermatological science, 2015-06, Vol.78 (3), p.167-172

2015

Link zum Volltext

Verfügbarkeit prüfen

Correlation between blood cell count and outcome of melanoma patients treated with anti-PD-1 antibodies

Japanese journal of clinical oncology, 2019-05, Vol.49 (5), p.431-437

2019

Link zum Volltext

Verfügbarkeit prüfen

Pathologic Features of Anti-Mi-2 Dermatomyositis

Neurology, 2021-01, Vol.96 (3), p.e448

2021

Link zum Volltext

Verfügbarkeit prüfen

The Onset of Food-dependent Exercise-induced Anaphylaxis in an Elderly Patient

Internal Medicine, 2023/10/01, Vol.62(19), pp.2907-2909

2023

Link zum Volltext

Verfügbarkeit prüfen

Inverted nipple-like nevus lipomatosus cutaneous superficialis

Japanese journal of clinical oncology, 2020-06, Vol.50 (6), p.722-723

2020

Link zum Volltext

Verfügbarkeit prüfen

The Role of PD-L1 on Langerhans Cells in the Regulation of Psoriasis

Journal of investigative dermatology, 2022-12, Vol.142 (12), p.3167-3174.e9

2022

Link zum Volltext

Verfügbarkeit prüfen

The Onset of Food-dependent Exercise-induced Anaphylaxis in an Elderly Patient: A Case Report

Internal Medicine, 2023, pp.0659-22

2023

Link zum Volltext

Verfügbarkeit prüfen

Serum level of interleukin-6 is increased in nivolumab-associated psoriasiform dermatitis and tumor necrosis factor-α is a biomarker of nivolumab recativity

Journal of dermatological science, 2017-04, Vol.86 (1), p.71-73

2017

Link zum Volltext

Verfügbarkeit prüfen

Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodies [version 1; peer review: 3 approved]

F1000 research, 2019, Vol.8, p.1951

2019

Link zum Volltext

Verfügbarkeit prüfen

Refractory dermatomyositis which developed in a patient with silicone breast implants

Allergology international, 2022-01, Vol.71 (1), p.158-160

2022

Link zum Volltext

Verfügbarkeit prüfen

Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathy

Rheumatology (Oxford, England), 2022-04, Vol.61 (4), p.e90-e92

2022

Link zum Volltext

Verfügbarkeit prüfen

Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash

Rheumatology (Oxford, England), 2022-03, Vol.61 (3), p.1222-1227

2022

Link zum Volltext

Verfügbarkeit prüfen

Depletion of PD-1 or PD-L1 did not affect the mortality of mice infected with Mycobacterium avium

Scientific reports, 2021-09, Vol.11 (1), p.18008-18008, Article 18008

2021

Link zum Volltext

Verfügbarkeit prüfen

The relationship between anti‐phosphatidylserine/prothrombin complex IgM antibodies and cutaneous ulcers in patients with cutaneous vasculitis

Journal of dermatology, 2021-09, Vol.48 (9), p.1457-1458

2021

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of apremilast, an oral phosphodiesterase 4 inhibitor, for refractory cutaneous dermatomyositis: A phase 1b clinical trial

Journal of dermatology, 2022-01, Vol.49 (1), p.118-123

2022

Link zum Volltext

Verfügbarkeit prüfen

Unilateral heliotrope rash: a warning sign for anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis

Rheumatology (Oxford, England), 2021-04, Vol.60 (4), p.e134-e135

2021

Link zum Volltext

Verfügbarkeit prüfen

NRF2 Augments Epidermal Antioxidant Defenses and Promotes Atopy

The Journal of immunology (1950), 2020-08, Vol.205 (4), p.907-914

2020

Link zum Volltext

Verfügbarkeit prüfen

A prospective, phase II study on the safety and efficacy of negative pressure closure for the stabilization of split‐thickness skin graft in large or muscle‐exposing defects: The NPSG study

Journal of dermatology, 2021-09, Vol.48 (9), p.1350-1356

2021

Link zum Volltext

Verfügbarkeit prüfen

Case of anti‐nuclear matrix protein 2 antibody‐positive juvenile dermatomyositis preceded by linear cutaneous lupus erythematosus on the face

Journal of dermatology, 2022-01, Vol.49 (1), p.e18-e19

2022

Link zum Volltext

Verfügbarkeit prüfen

Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis

Journal of dermatological science, 2016-12, Vol.84 (3), p.272-281

2016

Link zum Volltext

Verfügbarkeit prüfen

Murine models of idiopathic inflammatory myopathy

Immunological medicine, 2023-01, Vol.46 (1), p.9-14

2023

Link zum Volltext

Verfügbarkeit prüfen

A Case of Anti-NXP2 Antibody-positive Juvenile Dermatomyositis with Characteristic Fascial Thickening on Muscle Ultrasound and Improvement with Immunotherapy

Internal Medicine, 2024, pp.2720-23

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 242

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(183)
Mit Volltextzugriff
(235)

Publikationsform

Artikel
(203)
Berichte
(39)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Immune-related adverse events in various organs caused by immune checkpoint inhibitors

Clinical Features and Cutaneous Manifestations of Juvenile and Adult Patients of Dermatomyositis Associated with Myositis-Specific Autoantibodies

Recent advances in dermatomyositis-specific autoantibodies

Clinical perspectives and murine models of lichenoid tissue reaction/interface dermatitis

Correlation between blood cell count and outcome of melanoma patients treated with anti-PD-1 antibodies

Pathologic Features of Anti-Mi-2 Dermatomyositis

The Onset of Food-dependent Exercise-induced Anaphylaxis in an Elderly Patient

Inverted nipple-like nevus lipomatosus cutaneous superficialis

The Role of PD-L1 on Langerhans Cells in the Regulation of Psoriasis

The Onset of Food-dependent Exercise-induced Anaphylaxis in an Elderly Patient: A Case Report

Serum level of interleukin-6 is increased in nivolumab-associated psoriasiform dermatitis and tumor necrosis factor-α is a biomarker of nivolumab recativity

Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodies [version 1; peer review: 3 approved]

Refractory dermatomyositis which developed in a patient with silicone breast implants

Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathy

Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash

Depletion of PD-1 or PD-L1 did not affect the mortality of mice infected with Mycobacterium avium

The relationship between anti‐phosphatidylserine/prothrombin complex IgM antibodies and cutaneous ulcers in patients with cutaneous vasculitis

Evaluation of apremilast, an oral phosphodiesterase 4 inhibitor, for refractory cutaneous dermatomyositis: A phase 1b clinical trial

Unilateral heliotrope rash: a warning sign for anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis

NRF2 Augments Epidermal Antioxidant Defenses and Promotes Atopy

A prospective, phase II study on the safety and efficacy of negative pressure closure for the stabilization of split‐thickness skin graft in large or muscle‐exposing defects: The NPSG study

Case of anti‐nuclear matrix protein 2 antibody‐positive juvenile dermatomyositis preceded by linear cutaneous lupus erythematosus on the face

Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis

Murine models of idiopathic inflammatory myopathy

A Case of Anti-NXP2 Antibody-positive Juvenile Dermatomyositis with Characteristic Fascial Thickening on Muscle Ultrasound and Improvement with Immunotherapy

Suchergebnisse filtern